1

Chan KC et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem. 2004 Jan;50(1):88-92.

2

Heitzer E et al. Circulating Tumor DNA as a liquid Biopsy for cancer Clinical Chemistry. 2015 61:1 112-123

3

Perakis S et al. Advances in Circulating Tumor DNA Analysis Adv Clin Chem. 2017;80:73-153

4

Wan JC et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA Nat Rev Cancer. 2017 Apr;17(4):223-238

5

Lui YY et al. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem. 2002 Mar;48(3):421-7.

6

Lee TH et al. Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma. Transfusion. 2001 Feb;41(2):276-82

7

Thijssen MA et al. Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases. Anticancer Res. 2002 Jan-Feb;22(1A):421-5.

8

Lo YM et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998 Apr;62(4):768-75.

9

Lui YY et al. Circulating DNA in plasma and serum: biology, preanalytical issues and diagnostic applications. Clin Chem Lab Med. 2002 Oct;40(10):962-8.

10

Gautschi O et al. Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol. 2004 Oct 15;22(20):4157-64.

11

Nie K et al. Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer. Tumour Biol. 2015 Jan;36(1):7-19.

12

Chan KC et al. Effects of preanalytical factors on the molecular size of cell-free DNA in blood. Clin Chem. 2005 Apr;51(4):781-4.

13

Lo YM et al. Circulating nucleic acids in plasma and serum: an overview. Ann N Y Acad Sci. 2001 Sep;945:1-7.

14

van der Vaart M et al. Is the role of circulating DNA as a biomarker of cancer being prematurely overrated? Clin Biochem. 2010 Jan;43(1-2):26-36. 

15

Zinkova A et al. Cell-free DNA from human plasma and serum differs in content of telomeric sequences and its ability to promote immune response. Sci Rep. 2017 Jun 1;7(1):2591.

16

Wong FC et al. Cell-free DNA in maternal plasma and serum: A comparison of quantity, quality and tissue origin using genomic and epigenomic approaches. Clin Biochem. 2016 Dec;49(18):1379-1386.

17

Board RE et al. Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer. Ann N Y Acad Sci. 2008 Aug;1137:98-107.

18

Norton SE et al. A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR. Clin Biochem. 2013 Oct;46(15):1561-5. 

19

Perakis S et al. Advances in Circulating Tumor DNA Analysis Adv Clin Chem. 2017;80:73-153

20

Warrino DE et al. Stabilization of white blood cells and immunologic markers for extended analysis using flow cytometry. J Immunol Methods. 2005 Oct 30;305(2):107-19.

21

Fernando MR et al. A new methodology to preserve the original proportion and integrity of cell-free fetal DNA in maternal plasma during sample processing and storage. Prenat Diagn. 2010 May;30(5):418-24.

22

Wong D et al. Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing. Clin Biochem. 2013 Aug;46(12):1099-104

23

Das K et al. Effects of a novel cell stabilizing reagent on DNA amplification by PCR as compared to traditional stabilizing reagents. Acta Histochem. 2014 Jan;116(1):55-60.

24

Lam NY et al. Time course of early and late changes in plasma DNA in trauma patients. Clin Chem. 2003 Aug;49(8):1286-91.

25

Lo YM et al. Plasma DNA as a prognostic marker in trauma patients.  Clin Chem. 2000 Mar;46(3):319-23

26

Ren B et al. Is plasma cell-free DNA really a useful marker for diagnosis and treatment of trauma patients? Clin Chim Acta. 2013 Sep 23;424:109-13.

27

Saukkonen K et al. Association of cell-free plasma DNA with hospital mortality and organ dysfunction in intensive care unit patients. Intensive Care Med. 2007 Sep;33(9):1624-7.

28

Chou CC et al. Plasma nuclear DNA and mitochondrial DNA as prognostic markers in corrosive injury patients. Dig Surg. 2008;25(4):300-4.

29

Letendre JA et al. Measurement of plasma cell-free DNA concentrations in dogs with sepsis, trauma, and neoplasia. J Vet Emerg Crit Care (San Antonio). 2017 May;27(3):307-314.

30

Ahmed AI et al. Cell Free DNA and Procalcitonin as Early Markers of Complications in ICU Patients with Multiple Trauma and Major Surgery. Clin Lab. 2016 Dec 1;62(12):2395-2404. 

31

Rainer TH et al. Derivation of a prediction rule for posttraumatic organ failure using plasma DNA and other variables. Ann N Y Acad Sci. 2001 Sep;945:211-20.

32

Fox A et al. Quantification of circulating cell-free plasma DNA and endothelial gene RNA in patients with burns and relation to acute thermal injury. Burns. 2008 Sep;34(6):809-16. 

33

Ahmed AI et al. Elevated cell-free plasma DNA level as an independent predictor of mortality in patients with severe traumatic brain injury. J Neurotrauma. 2014 Oct 1;31(19):1639-46. 

34

Gould TJ et al. Extracellular DNA and histones: double-edged swords in immunothrombosis. J Thromb Haemost. 2015 Jun;13 Suppl 1:S82-91. 

35

G?genur M et al. The role of total cell-free DNA in predicting outcomes among trauma patients in the intensive care unit: a systematic review. Crit Care. 2017 Jan 24;21(1):14.

36

Fournié GJ et al. Plasma DNA as cell death marker in elderly patients. Gerontology. 1993;39(4):215-21.

37

Wijeratne S et al. Cell-free plasma DNA as a prognostic marker in intensive treatment unit patients. Ann N Y Acad Sci. 2004 Jun;1022:232-8.

38

Fournié GJ et al. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett. 1995 May 8;91(2):221-7.

39

Korzeneva IB et al. Human circulating plasma DNA significantly decreases while lymphocyte DNA damage increases under chronic occupational exposure to low-dose gamma-neutron and tritium β-radiation. Mutat Res. 2015 Sep;779:1-15.

40

Opatrna S et al. Cell-free plasma DNA during Hemodialysis. Ren Fail. 2009;31(6):475-80.

41

Brinkmann V et al. Neutrophil extracellular traps kill bacteria. Science. 2004 Mar 5;303(5663):1532-5.

42

Swystun LL et al. Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus. J Thromb Haemost. 2011 Nov;9(11):2313-21. 

43

Gould TJ et al. Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms. Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1977-84. 

44

Fuchs TA et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007 Jan 15;176(2):231-41.

45

Jiménez-Alcázar M et al. Circulating Extracellular DNA: Cause or Consequence of Thrombosis? Semin Thromb Hemost. 2017 Mar 30.

46

Kim SJ et al. Role of platelets in neutrophil extracellular trap (NET) production and tissue injury. Semin Immunol. 2016 Dec;28(6):546-554. 

47

Jansen MP et al. Release of extracellular DNA influences renal ischemia reperfusion injury by platelet activation and formation of neutrophil extracellular traps. Kidney Int. 2017 Feb;91(2):352-364. 

48

Gould TJ et al. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis. Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2544-53.

49

Andrews RK et al. Neutrophil extracellular traps (NETs) and the role of platelets in infection. Thromb Haemost. 2014 Oct;112(4):659-65. 

50

Schneck E et al. Plasma DNA and RNA differentially impact coagulation during abdominal sepsis-an explorative study. J Surg Res. 2017 Apr;210:231-243.

51

Fournié GJ et al. Extracellular DNA and histones: double-edged swords in immunothrombosis. J Thromb Haemost. 2015 Jun;13 Suppl 1:S82-91.